Adelaide Research & Scholarship: Browsing DSpace

Browsing "Pharmacology" by Title

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:

Showing results 879 to 898 of 918 < previous next >

Issue Date	Title	Author(s)
2018	Total flavonoid extract of Epimedium herb increases the peak bone mass of young rats involving enhanced activation of the AC10/cAMP/PKA/CREB pathway	Xi, H.R.; Ma, H.P.; Yang, F.F.; Gao, Y.H.; Zhou, J.; Wang, Y.Y.; Li, W.Y.; Xian, C.J.; Chen, K.M.
2014	Towards finding a population biomarker for wastewater epidemiology studies	Chen, C.; Kostakis, C.; Gerber, J.; Tscharke, B.; Irvine, R.; White, J.
2001	Toxic cyanobacterial bloom problems in Australian waters: risks and impacts on human health	Falconer, I.
2012	Toxicity of the cyanobacterium Limnothrix AC0243 to male Balb/c mice	Humpage, A.; Falconer, I.; Bernard, C.; Froscio, S.; Fabbro, L.
2008	Toxin types, toxicokinetics and toxicodynamics	Humpage, A.; ISOC-HAB (2005 : NC, USA)
1995	Treating Hypertension in the Elderly	Tonkin, Anne L.
2001	Treating-to-risk - An approach to managing absolute CVD risk and hypertension	HamiltonCraig, C.; Tonkin, A.
2021	Treatment of cystic fibrosis: from gene- to cell-based therapies	Allan, K.M.; Farrow, N.; Donnelley, M.; Jaffe, A.; Waters, S.A.
1996	Tumour promotion by cyanobacterial toxins.	Falconer, I.; Humpage, A.
2003	UDP-glucuronosyltransferase-dependent bioactivation of clofibric acid to a DNA-damaging intermediate in mouse hepatocytes	Ghaoui, R.; Sallustio, B.; Burcham, P.; Fontaine, F.
2013	Ultra-rapid screening for substance-use disorders: The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST-Lite)	Ali, R.; Meena, S.; Eastwood, B.; Richards, I.; Marsden, J.
2014	Understanding the pharmacology of headache	Rolan, P.
2009	Unfaithful neurotransmitter transporters: focus on serotonin updake and implications for antidepressant efficacy	Daws, L.
2010	United Nations Office on Drugs and Crime International Network of Drug Dependence Treatment and Rehabilitation Resource Centres: Treatnet	Tomas-Rossello, J.; Rawson, R.; Zarza, M.; Bellows, A.; Busse, A.; Saenz, E.; Freese, T.; Shawkey, M.; Carise, D.; Ali, R.; Ling, W.
2003	Use of biomarkers from drug discovery through clinical practice: Report of the Ninth European Federation of Pharmaceutical Sciences Conference on Optimizing Drug Development	Rolan, Paul Edward; Atkinson, Arthur J.; Lesko, L. J.
2019	Use of medicines that may exacerbate heart failure in older adults: therapeutic complexity of multimorbidity	Caughey, G.E.; Shakib, S.; Barratt, J.D.; Roughead, E.E.
2004	Use of radiotelemetry to evaluate respiratory depression produced by chronic methadone administration	Lewanowitsch, T.; White, J.; Irvine, R.
2013	Use of serotonergic antidepressants and St John's wort in older Australians: A population-based cohort study	Rahman, S.; Basilakis, J.; Rahmadi, A.; Lujic, S.; Musgrave, I.; Jorm, L.; Hay, P.; Munch, G.
2021	Using data linkage for national surveillance of clinical quality indicators for dementia care among Australian aged care users	Cations, M.; Lang, C.; Ward, S.A.; Caughey, G.E.; Crotty, M.; Whitehead, C.; Ahern, S.; Maddison, J.; Inacio, M.C.
2018	Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study	Larney, S.; Hickman, M.; Fiellin, D.A.; Dobbins, T.; Nielsen, S.; Jones, N.R.; Mattick, R.P.; Ali, R.; Degenhardt, L.

Showing results 879 to 898 of 918 < previous next >